Dechra Pharmaceuticals

FTSE Russell

11 January 2024

 

Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion,  please note the replacement in the fixed indices. All other details remain unchanged. Please see updated notice below:

Dechra Pharmaceuticals (UK): Constituent Deletion - Update
Changes in FTSE UK Index Series

11 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index. Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index. Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index. All changes effective from 16 January 2024 Full details of index changes are available on the FTSE Russell website.

For further information please contact FTSE Russell Client Services at [e-mail] or call: Australia [phone] Hong Kong [phone] Japan [phone] London [phone] New York [phone] Alternatively please visit our website at lseg.com/ftse-russell Terms of Use | Copyright © 2024 FTSE Russell

 

END